Form 4 for SVRA Savara Inc
Accepted 2025-10-22 00:00:00 ET · period of report 2025-10-20 · accession 0002092127-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-10-22 | 2025-10-20 | SVRA | Wasfi Yasmine | Chief Medical Off | A - Grant | $0.00 | +35.0K | 190.0K | +23% | $0 |
| D | 2025-10-22 | 2025-10-20 | SVRA | Wasfi Yasmine | Chief Medical Off | A - Grant | $0.00 | +70.0K | 70.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-20 | A | A | 35,000 | $0.00 | 190,000 | D | — | — | (F1) Represents restricted stock units ("RSUs") that vest in full on October 17, 2027, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock. |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-10-20 | A | A | 70,000 | $0.00 | 70,000 | D | $4.11 · — to 2035-10-20 | 70,000 Common Stock | (F2) The option vests and becomes exercisable in sixteen equal installments on each quarterly anniversary of October 17, 2025, subject to the reporting person's continued service with the Issuer. |